Drug Discovery

share

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland...

share

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment...

share

AbbVie Inc said on Friday it had received European approval to market its drug for treatment of all...

share

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo, Japan-based Eisai Co., Ltd., and Johns Hopkins University announced today...

share

Mylan announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference...

5 shares

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it...

share

Swedish Orphan Biovitrum has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for...

share

Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule...